Clinical Trials Browser

Phase 1 × Prostatic Neoplasms × Panobinostat × Clear all

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00493766 2020-12-19

Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone

Phase 1 Terminated

16 enrolled

Genitourinary

Prostatic Neoplasms

NCT00419536 2010-04-08

Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone

Phase 1 Terminated

108 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone

Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone